Tellgen

Tellgen Graham Number

The Graham Number of Tellgen (300642.SZ) as of Nov 9, 2026 is 2.09 CNY. In the previous year, Graham Number was 6.68 CNY — a change of -68.68% (lower).

Graham Number

2.09CNY

YoY

-68.68%

Last updated:

Graham Number of Tellgen is 2025 2.09 CNY. Graham Number of Tellgen was 2024 6.68 CNY. It decreases by -68.68% lower compared to the previous year.

The Tellgen Graham Number history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Graham Number
Date
Graham Number
Jan 1, 2018
11.28 CNY
Jan 1, 2019
12.47 CNY
Jan 1, 2020
11.47 CNY
Jan 1, 2021
13.64 CNY
Jan 1, 2022
12.54 CNY
Jan 1, 2023
10.79 CNY
Jan 1, 2024
6.68 CNY
Jan 1, 2025
2.09 CNY
The Tellgen Graham Number history
YEARGraham NumberYoY
2.09CNY-68.68%
6.68CNY-38.11%
10.79CNY-13.98%
12.54CNY-8.06%
13.64CNY+18.91%
11.47CNY-7.98%
12.47CNY+10.51%
11.28CNY+14.96%
9.81CNY+73.55%
5.65CNY+49.25%
3.79CNY+88.69%
2.01CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tellgen Stock analysis

What does Tellgen do? Tellgen Corp develops, manufactures, and markets molecular diagnostic products including immunodiagnostic, molecular diagnostic, and biochemical diagnostic products. Their portfolio features tumor marker detection, HPV nucleic acid testing, autoimmune disease detection, and lung cancer methylation mutation detection products. The company targets healthcare providers and laboratories seeking advanced diagnostic solutions for disease detection and monitoring. Tellgen Corp generates revenue through the sale of these specialized diagnostic products to medical institutions and healthcare facilities. The firm's product lines focus on specific diagnostic needs such as cancer screening and infectious disease testing. Immunodiagnostic products detect antibodies and antigens, molecular diagnostic products analyze genetic material, and biochemical diagnostic products measure metabolic markers. Tellgen Corp sells these products directly to hospitals, clinics, and diagnostic laboratories across China and potentially internationally. Tellgen Corp's revenue streams come from the commercialization of its diagnostic product portfolio. The company's offerings address key healthcare challenges including early cancer detection and infectious disease management. Their products are designed to support clinical decision-making and patient care pathways in medical settings. Tellgen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tellgen stock

Graham Number of Tellgen is 2.09 CNY in 2025.

On Eulerpool you can find the complete historical development of Graham Number Tellgen since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Tellgen

All Key Metrics — Tellgen